358 related articles for article (PubMed ID: 23730837)
41. Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection.
Qi FH; Wang ZX; Cai PP; Zhao L; Gao JJ; Kokudo N; Li AY; Han JQ; Tang W
Drug Discov Ther; 2013 Dec; 7(6):212-24. PubMed ID: 24423652
[TBL] [Abstract][Full Text] [Related]
42. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
43. The effect of Gankang Suppository on duck hepatitis B virus, serum biochemistry and liver histology in ducklings.
Li H; Tian D; Wu H; Chen M; Chen A
J Huazhong Univ Sci Technolog Med Sci; 2008 Aug; 28(4):421-5. PubMed ID: 18704303
[TBL] [Abstract][Full Text] [Related]
44. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
45. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
46. Antisense therapy of hepatitis B virus infection.
Offensperger WB; Offensperger S; Blum HE
Mol Biotechnol; 1998 Apr; 9(2):161-70. PubMed ID: 9658393
[TBL] [Abstract][Full Text] [Related]
47. [Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Chen Y; Guo S; Qi Z; Huang A
Zhonghua Gan Zang Bing Za Zhi; 2001 Aug; 9(4):209-11. PubMed ID: 11602049
[TBL] [Abstract][Full Text] [Related]
48. Three new anti-HBV active constituents from the traditional Chinese herb of Yin-Chen (Artemisia scoparia).
Geng CA; Huang XY; Chen XL; Ma YB; Rong GQ; Zhao Y; Zhang XM; Chen JJ
J Ethnopharmacol; 2015 Dec; 176():109-17. PubMed ID: 26505294
[TBL] [Abstract][Full Text] [Related]
49. Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.
Liu Y; Yao W; Si L; Hou J; Wang J; Xu Z; Li W; Chen J; Li R; Li P; Bo L; Xiao X; Lan J; Xu D
Antiviral Res; 2018 Jul; 155():39-47. PubMed ID: 29702120
[TBL] [Abstract][Full Text] [Related]
50. Helioxanthin analogue 8-1 inhibits duck hepatitis B virus replication in cell culture.
Ying C; Tan S; Cheng YC
Antivir Chem Chemother; 2010; 21(2):97-103. PubMed ID: 21107018
[TBL] [Abstract][Full Text] [Related]
51. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
[TBL] [Abstract][Full Text] [Related]
52. [Experimental study on anti-duck hepatitis B viral effect of Phyllanthus urinaria of different areas and combined therapy with other drugs].
Chen YX; Guo SH; Zhang DF
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Apr; 15(4):225-7. PubMed ID: 7647546
[TBL] [Abstract][Full Text] [Related]
53. [Effect of ampelopsis of Ampelopsis grossedentata on duck hepatitis B virus].
Yan L; Zheng Z
Zhongguo Zhong Yao Za Zhi; 2009 Apr; 34(7):908-10. PubMed ID: 19623994
[TBL] [Abstract][Full Text] [Related]
54. [Study on the Rheum palmatum volatile oil against HBV in cell culture in vitro].
Zhang B; Chen J; Li H; Xu X
Zhong Yao Cai; 1998 Oct; 21(10):524-6. PubMed ID: 12569832
[TBL] [Abstract][Full Text] [Related]
55. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Seignères B; Martin P; Werle B; Schorr O; Jamard C; Rimsky L; Trépo C; Zoulim F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1842-52. PubMed ID: 12760857
[TBL] [Abstract][Full Text] [Related]
56. An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patients.
Debing Y; Vanrusselt H; Degrauwe L; Silva de Oliveira DA; Kariuki CK; Ebwanga EJ; Bashir S; Merckx W; Thatikonda SK; Rajwanshi V; Gohil V; Hong J; Kum DB; Acosta Sanchez A; Chanda S; Blatt LM; Jekle A; Symons JA; Smith DB; Raboisson P; Lin TI; Beigelman L; Paeshuyse J
Antiviral Res; 2024 Apr; 224():105835. PubMed ID: 38401714
[TBL] [Abstract][Full Text] [Related]
57. Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.
Noordeen F; Vaillant A; Jilbert AR
Antimicrob Agents Chemother; 2013 Nov; 57(11):5299-306. PubMed ID: 23939904
[TBL] [Abstract][Full Text] [Related]
58. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
59. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]